Ignite Creation Date:
2025-12-25 @ 4:15 AM
Ignite Modification Date:
2026-05-03 @ 3:09 PM
Study NCT ID:
NCT00039520
Status:
COMPLETED
Last Update Posted:
2014-05-06
First Post:
2002-06-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sulindac and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer
Sponsor:
Fox Chase Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CDR0000069390
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |